Health care stocks were advancing in Tuesday afternoon trading, with the NYSE Health Care Index adding 0.4% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%.
The iShares Biotechnology ETF (IBB) fell 0.7%.
In corporate news, Janux Therapeutics (JANX) shares soared 56%. The company reported late Monday positive interim clinical data for its JANX007 clinical program in prostate cancer patients.
Rezolute (RZLT) shares jumped 5.8% after the company said Tuesday the US Food and Drug Administration granted orphan drug designation to ersodetug to treat hypoglycemia caused by tumor hyperinsulinism.
TransMedics' (TMDX) shares tumbled past 15% in recent trading, a day after the company said it named Gerardo Hernandez as chief financial officer.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。